Cilostazol and Neupro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 12 people who take Cilostazol and Neupro. Common interactions include death among females, and aggression among males.

The phase IV clinical study analyzes what interactions people who take Cilostazol and Neupro have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2023

12 people who take Cilostazol and Neupro together, and have interactions are studied.


What is Cilostazol?

Cilostazol has active ingredients of cilostazol. It is used in arteriosclerosis of the extremities. Currently, eHealthMe is studying from 7,513 Cilostazol users.

What is Neupro?

Neupro has active ingredients of rotigotine. It is used in parkinson's disease. Currently, eHealthMe is studying from 10,794 Neupro users.

Number of Cilostazol and Neupro reports submitted per year:

Cilostazol and Neupro drug interactions.

Common Cilostazol and Neupro drug interactions by gender *:

female:

  1. Death
  2. Dehydration
  3. Genital infection female
  4. Sepsis
  5. Urinary tract infection
  6. Vomiting

male:

  1. Aggression
  2. Altered state of consciousness
  3. Device occlusion
  4. Diarrhoea
  5. Dizziness
  6. Epilepsy
  7. Extrapyramidal disorder
  8. Fibrosis
  9. Hypotension
  10. Insomnia


Common Cilostazol and Neupro drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Aggression
  2. Altered state of consciousness
  3. Delirium
  4. Device occlusion
  5. Diarrhoea
  6. Dizziness
  7. Epilepsy
  8. Extrapyramidal disorder
  9. Fibrosis
  10. Hypotension

Common conditions people have *:

  1. Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 33.33%
  2. Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 8.33%
  3. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%
  4. Constipation: 1 person, 8.33%
  5. Delusion (a false belief or opinion): 1 person, 8.33%
  6. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue): 1 person, 8.33%
  7. Hallucinations (sensations that appear real but are created by your mind): 1 person, 8.33%
  8. High Blood Cholesterol: 1 person, 8.33%
  9. High Blood Pressure: 1 person, 8.33%
  10. Insomnia (sleeplessness): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cilostazol and Neupro?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Drug side effects by duration, gender and age:

Common Cilostazol drug interactions:

Browse interactions between Cilostazol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Neupro drug interactions:

Browse interactions between Neupro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cilostazol and rotigotine (the active ingredients of Cilostazol and Neupro, respectively), and Cilostazol and Neupro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cilostazol and Neupro.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: